HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons

In 2016, the WHO announced a plan to eliminate viral hepatitis as a public health threat by 2030. In this narrative review, experts from Bulgaria, Croatia, the Czech Republic, Hungary, Latvia, Lithuania, Poland and Slovakia assessed the feasibility of achieving the WHO 2030 target for HCV infections...

Full description

Bibliographic Details
Main Authors: Robert Flisiak, Dorota Zarębska-Michaluk, Egle Ciupkeviciene, Sylvia Drazilova, Sona Frankova, Ivica Grgurevic, Bela Hunyady, Peter Jarcuska, Limas Kupčinskas, Michael Makara, Gunita Saulite-Vanaga, Marieta Simonova, Jan Sperl, Ieva Tolmane, Adriana Vince
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/14/3/482
_version_ 1797441019412742144
author Robert Flisiak
Dorota Zarębska-Michaluk
Egle Ciupkeviciene
Sylvia Drazilova
Sona Frankova
Ivica Grgurevic
Bela Hunyady
Peter Jarcuska
Limas Kupčinskas
Michael Makara
Gunita Saulite-Vanaga
Marieta Simonova
Jan Sperl
Ieva Tolmane
Adriana Vince
author_facet Robert Flisiak
Dorota Zarębska-Michaluk
Egle Ciupkeviciene
Sylvia Drazilova
Sona Frankova
Ivica Grgurevic
Bela Hunyady
Peter Jarcuska
Limas Kupčinskas
Michael Makara
Gunita Saulite-Vanaga
Marieta Simonova
Jan Sperl
Ieva Tolmane
Adriana Vince
author_sort Robert Flisiak
collection DOAJ
description In 2016, the WHO announced a plan to eliminate viral hepatitis as a public health threat by 2030. In this narrative review, experts from Bulgaria, Croatia, the Czech Republic, Hungary, Latvia, Lithuania, Poland and Slovakia assessed the feasibility of achieving the WHO 2030 target for HCV infections in Central Europe. They focused mainly on HCV micro-elimination in prisons, where the highest incidence of HCV infections is usually observed, and the impact of the COVID-19 pandemic on the detection and treatment of HCV infections. According to the presented estimates, almost 400,000 people remain infected with HCV in the analyzed countries. Interferon-free therapies are available ad libitum, but the number of patients treated annually in the last two years has halved compared to 2017–2019, mainly due to the COVID-19 pandemic. None of the countries analyzed had implemented a national HCV screening program or a prison screening program. The main reason is a lack of will at governmental and prison levels. None of the countries analyzed see any chance of meeting the WHO targets for removing viral hepatitis from the public threat list by 2030, unless barriers such as a lack of political will and a lack of screening programs are removed quickly.
first_indexed 2024-03-09T12:16:52Z
format Article
id doaj.art-73899e61351e4c9d9d7ca054a09abb60
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-09T12:16:52Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-73899e61351e4c9d9d7ca054a09abb602023-11-30T22:45:12ZengMDPI AGViruses1999-49152022-02-0114348210.3390/v14030482HCV Elimination in Central Europe with Particular Emphasis on Microelimination in PrisonsRobert Flisiak0Dorota Zarębska-Michaluk1Egle Ciupkeviciene2Sylvia Drazilova3Sona Frankova4Ivica Grgurevic5Bela Hunyady6Peter Jarcuska7Limas Kupčinskas8Michael Makara9Gunita Saulite-Vanaga10Marieta Simonova11Jan Sperl12Ieva Tolmane13Adriana Vince14Department of Infectious Diseases and Hepatology, Medical University of Białystok, 15-540 Białystok, PolandDepartment of Infectious Diseases, Jan Kochanowski University, 25-317 Kielce, PolandDepartment of Gastroenterology, Lithuanian University of Health Sciences, LT50061 Kaunas, Lithuania2nd Department of Internal Medicine, L Pasteur University Hospital and PJ Safarik University, Faculty of Medicine, 04011 Kosice, SlovakiaDepartment of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech RepublicDepartment of Gastroenterology, Hepatology and Clinical Nutrition, University of Zagreb, University Hospital Dubrava, 10000 Zagreb, CroatiaDepartment of Gastroenterolgy, Somogy Megyei Kaposi Mór Oktató Kórház, H7400 Kaposvár, Hungary2nd Department of Internal Medicine, L Pasteur University Hospital and PJ Safarik University, Faculty of Medicine, 04011 Kosice, SlovakiaDepartment of Gastroenterology, Lithuanian University of Health Sciences, LT50061 Kaunas, LithuaniaCentral Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Saint Laszlo Hospital, 5-7. Albert Florian Street, H1097 Budapest, HungaryOut-Patient Department, Riga East University Hospital, Latvian Center of Infectious Diseases, LV1013 Riga, LatviaDepartment of HPB Surgery and Transplantology, Clinic of Gastroenterology, Military Medical Academy, 1606 Sofia, BulgariaDepartment of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech RepublicOut-Patient Department, Riga East University Hospital, Latvian Center of Infectious Diseases, LV1013 Riga, LatviaDepartment of Infectious Diseases, Medical School University of Zagreb, University Hospital of Infectious Diseases, 10000 Zagreb, CroatiaIn 2016, the WHO announced a plan to eliminate viral hepatitis as a public health threat by 2030. In this narrative review, experts from Bulgaria, Croatia, the Czech Republic, Hungary, Latvia, Lithuania, Poland and Slovakia assessed the feasibility of achieving the WHO 2030 target for HCV infections in Central Europe. They focused mainly on HCV micro-elimination in prisons, where the highest incidence of HCV infections is usually observed, and the impact of the COVID-19 pandemic on the detection and treatment of HCV infections. According to the presented estimates, almost 400,000 people remain infected with HCV in the analyzed countries. Interferon-free therapies are available ad libitum, but the number of patients treated annually in the last two years has halved compared to 2017–2019, mainly due to the COVID-19 pandemic. None of the countries analyzed had implemented a national HCV screening program or a prison screening program. The main reason is a lack of will at governmental and prison levels. None of the countries analyzed see any chance of meeting the WHO targets for removing viral hepatitis from the public threat list by 2030, unless barriers such as a lack of political will and a lack of screening programs are removed quickly.https://www.mdpi.com/1999-4915/14/3/482hepatitisHCVWHOepidemiologytherapyscreening
spellingShingle Robert Flisiak
Dorota Zarębska-Michaluk
Egle Ciupkeviciene
Sylvia Drazilova
Sona Frankova
Ivica Grgurevic
Bela Hunyady
Peter Jarcuska
Limas Kupčinskas
Michael Makara
Gunita Saulite-Vanaga
Marieta Simonova
Jan Sperl
Ieva Tolmane
Adriana Vince
HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
Viruses
hepatitis
HCV
WHO
epidemiology
therapy
screening
title HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
title_full HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
title_fullStr HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
title_full_unstemmed HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
title_short HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
title_sort hcv elimination in central europe with particular emphasis on microelimination in prisons
topic hepatitis
HCV
WHO
epidemiology
therapy
screening
url https://www.mdpi.com/1999-4915/14/3/482
work_keys_str_mv AT robertflisiak hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT dorotazarebskamichaluk hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT egleciupkeviciene hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT sylviadrazilova hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT sonafrankova hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT ivicagrgurevic hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT belahunyady hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT peterjarcuska hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT limaskupcinskas hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT michaelmakara hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT gunitasaulitevanaga hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT marietasimonova hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT jansperl hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT ievatolmane hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons
AT adrianavince hcveliminationincentraleuropewithparticularemphasisonmicroeliminationinprisons